{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:25:39Z","timestamp":1790378739219,"version":"4.1.0"},"reference-count":48,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b17-00733","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T22:25:50Z","timestamp":1517437550000},"page":"213-219","source":"Crossref","is-referenced-by-count":12,"title":["Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats"],"prefix":"10.1248","volume":"41","author":[{"given":"Hiroshi","family":"Kawai","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Machida","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mitsumoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. <i>Nat. Rev. Neurosci.<\/i>, <b>4<\/b>, 649\u2013661 (2003)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. <i>Mol. Med.<\/i>, <b>18<\/b>, 1249\u20131260 (2012).","DOI":"10.2119\/molmed.2012.00077"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Takeda N, Maemura K. Circadian clock and cardiovascular disease. <i>J. Cardiol.<\/i>, <b>57<\/b>, 249\u2013256 (2011).","DOI":"10.1016\/j.jjcc.2011.02.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. <i>Nat. Rev. Neurosci.<\/i>, <b>11<\/b>, 589\u2013599 (2010).","DOI":"10.1038\/nrn2868"},{"key":"5","unstructured":"5) Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>47<\/b>, 593\u2013628 (2007)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ohdo S, Koyanagi S, Matsunaga N, Hamdan A. Molecular basis of chronopharmaceutics. <i>J. Pharm. Sci.<\/i>, <b>100<\/b>, 3560\u20133576 (2011).","DOI":"10.1002\/jps.22656"},{"key":"7","unstructured":"7) Dallmann R, Brown SA, Gachon F. Chronopharmacology: new insights and therapeutic implications. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>54<\/b>, 339\u2013361 (2014)."},{"key":"8","unstructured":"8) Ohdo S. Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. <i>Adv. Drug Deliv. Rev.<\/i>, <b>62<\/b>, 859\u2013875 (2010)."},{"key":"9","unstructured":"9) Au J, Reece J. The relationship between chronotype and depressive symptoms: a meta-analysis. <i>J. Affect. Disord.<\/i>, <b>218<\/b>, 93\u2013104 (2017)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Moffoot APR, O\u2019Carroll RE, Bennie J, Carroll S, Dick H, Ebmeier KP, Goodwin GM. Diurnal variation of mood and neuropsychological function in major depression with melancholia. <i>J. Affect. Disord.<\/i>, <b>32<\/b>, 257\u2013269 (1994).","DOI":"10.1016\/0165-0327(94)90090-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>103<\/b>, 7414\u20137419 (2006).","DOI":"10.1073\/pnas.0602425103"},{"key":"12","unstructured":"12) Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. <i>Am. J. Psychiatry<\/i>, <b>162<\/b>, 656\u2013662 (2005)."},{"key":"13","unstructured":"13) Bechtel W. Circadian rhythms and mood disorders: are the phenomena and mechanisms causally related? <i>Front. Psychiatry<\/i>, <b>6<\/b>, 118 (2015)."},{"key":"14","unstructured":"14) Kronfeld-Schor N, Einat H. Circadian rhythms and depression: human psychopathology and animal models. <i>Neuropharmacology<\/i>, <b>62<\/b>, 101\u2013114 (2012)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. <i>Nat. Protoc.<\/i>, <b>7<\/b>, 1009\u20131014 (2012).","DOI":"10.1038\/nprot.2012.044"},{"key":"16","unstructured":"16) Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. <i>Nature<\/i>, <b>266<\/b>, 730\u2013732 (1977)."},{"key":"17","unstructured":"17) Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. <i>Trends Pharmacol. Sci.<\/i>, <b>23<\/b>, 238\u2013245 (2002)."},{"key":"18","unstructured":"18) Lim DW, Jung J-W, Park J-H, Baek N-I, Kim YT, Kim I-H, Han D. Antidepressant-like effects of Sanggenon G, isolated from the root bark of <i>Morus alba<\/i>, in rats: involvement of the serotonergic system. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 1772\u20131778 (2015)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nagayama H. Influences of biological rhythms on the effects of psychotropic drugs. <i>Psychosom. Med.<\/i>, <b>61<\/b>, 618\u2013629 (1999).","DOI":"10.1097\/00006842-199909000-00006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ushijima K, Sakaguchi H, Sato Y, To H, Koyanagi S, Higuchi S, Ohdo S. Chronopharmacological study of antidepressants in forced swimming test of mice. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>315<\/b>, 764\u2013770 (2005).","DOI":"10.1124\/jpet.105.088849"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nakano S, Hollister LE. Chronopharmacology of amitriptyline. <i>Clin. Pharmacol. Ther.<\/i>, <b>33<\/b>, 453\u2013459 (1983).","DOI":"10.1038\/clpt.1983.61"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nagayama H, Nagano K, Ikezaki A, Tashiro T. Double-blind study of the chronopharmacotherapy of depression. <i>Chronobiol. Int.<\/i>, <b>8<\/b>, 203\u2013209 (1991).","DOI":"10.3109\/07420529109063927"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Srinivas NR, Shyu WC, Gleason C, Schuster A, Greene DS, Barbhaiya RH. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. <i>Clin. Pharmacol. Ther.<\/i>, <b>62<\/b>, 408\u2013416 (1997).","DOI":"10.1016\/S0009-9236(97)90119-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Bougerolle AM, Chabard JL, Jbilou M, Dordain G, Eschalier A, Aumaitre O, Gaillot J, Piron JJ, Petit J, Berger JA. Chronopharmacokinetic and bioequivalence studies of two formulations of trimipramine after oral administration in man. <i>Eur. J. Drug Metab. Pharmacokinet.<\/i>, <b>14<\/b>, 139\u2013144 (1989).","DOI":"10.1007\/BF03190854"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. <i>Psychopharmacology<\/i>, <b>121<\/b>, 66\u201372 (1995).","DOI":"10.1007\/BF02245592"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Detke MJ, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. <i>Exp. Clin. Psychopharmacol.<\/i>, <b>5<\/b>, 107\u2013112 (1997).","DOI":"10.1037\/\/1064-1297.5.2.107"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. <i>Psychopharmacology<\/i>, <b>147<\/b>, 162\u2013167 (1999).","DOI":"10.1007\/s002130051156"},{"key":"29","unstructured":"29) Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. <i>Trends Pharmacol. Sci.<\/i>, <b>23<\/b>, 238\u2013245 (2002)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) R\u00e9n\u00e9ric JP, Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. <i>Psychopharmacology<\/i>, <b>136<\/b>, 190\u2013197 (1998).","DOI":"10.1007\/s002130050555"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? <i>Psychopharmacology<\/i>, <b>94<\/b>, 147\u2013160 (1988).","DOI":"10.1007\/BF00176837"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain <i>in vitro.<\/i> <i>J. Pharmacol. Exp. Ther.<\/i>, <b>230<\/b>, 94\u2013102 (1984).","DOI":"10.1016\/S0022-3565(25)21446-X"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Doze VA, Handel EM, Jensen KA, Darsie B, Luger EJ, Haselton JR, Talbot JN, Rorabaugh BR. \u03b1<sub>1A<\/sub>- and \u03b1<sub>1B<\/sub>-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. <i>Brain Res.<\/i>, <b>1285<\/b>, 148\u2013157 (2009).","DOI":"10.1016\/j.brainres.2009.06.035"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Caccia S. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. <i>Clin. Pharmacokinet.<\/i>, <b>34<\/b>, 281\u2013302 (1998).","DOI":"10.2165\/00003088-199834040-00002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Quay WB. Regional and circadian differences in cerebral cortical serotonin concentrations. <i>Life Sci.<\/i>, <b>4<\/b>, 379\u2013384 (1965).","DOI":"10.1016\/0024-3205(65)90156-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Bhaskaran D, Radha E. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age. <i>Exp. Gerontol.<\/i>, <b>19<\/b>, 153\u2013170 (1984).","DOI":"10.1016\/0531-5565(84)90034-2"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. <i>Psychopharmacology<\/i>, <b>162<\/b>, 323\u2013332 (2002).","DOI":"10.1007\/s00213-002-1111-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. <i>Physiol. Rev.<\/i>, <b>72<\/b>, 165\u2013229 (1992).","DOI":"10.1152\/physrev.1992.72.1.165"},{"key":"39","unstructured":"39) Foote SL, Bloom FE, Aston-Jones G. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. <i>Physiol. Rev.<\/i>, <b>63<\/b>, 844\u2013914 (1983)."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. <i>Arch. Gen. Psychiatry<\/i>, <b>46<\/b>, 243\u2013250 (1989).","DOI":"10.1001\/archpsyc.1989.01810030049007"},{"key":"41","unstructured":"41) Harvey P-O, Fossati P, Pochon J-B, Levy R, LeBastard G, Leh\u00e9ricy S, Allilaire J-F, Dubois B. Cognitive control and brain resources in major depression: An fMRI study using the <i>n<\/i>-back task. <i>Neuroimage<\/i>, <b>26<\/b>, 860\u2013869 (2005)."},{"key":"42","unstructured":"42) Wagner G, Sinsel E, Sobanski T, K\u00f6hler S, Marinou V, Mentzel H-J, Sauer H, Schl\u00f6sser RGM. Cortical inefficiency in patients with unipolar depression: An event-related fMRI study with the Stroop Task. <i>Biol. Psychiatry<\/i>, <b>59<\/b>, 958\u2013965 (2006)."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Sairanen M, O\u2019Leary OF, Knuuttila JE, Castr\u00e9n E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. <i>Neuroscience<\/i>, <b>144<\/b>, 368\u2013374 (2007).","DOI":"10.1016\/j.neuroscience.2006.08.069"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. <i>J. Neurosci.<\/i>, <b>20<\/b>, 9104\u20139110 (2000).","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of Hippocampal neurogenesis for the behavioral effects of antidepressants. <i>Science<\/i>, <b>301<\/b>, 805\u2013809 (2003).","DOI":"10.1126\/science.1083328"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lu JQ, Nagayama H. Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats. <i>Psychopharmacology<\/i>, <b>123<\/b>, 42\u201345 (1996).","DOI":"10.1007\/BF02246279"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Moser PC, Redfern PH. Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse. <i>Psychopharmacology<\/i>, <b>86<\/b>, 223\u2013227 (1985).","DOI":"10.1007\/BF00431714"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Nagayama H, Lu J-Q. Circadian rhythm in the responsiveness of central 5-HT2A receptor to DOI in rats. <i>Psychopharmacology<\/i>, <b>127<\/b>, 113\u2013116 (1996).","DOI":"10.1007\/BF02805983"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00733\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:48:35Z","timestamp":1751280515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00733\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00733","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}